Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qidan Dihuang
- Development stage
- Preclinical
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Administration
- Oral
01
Overview
Qidan Dihuang is a traditional Chinese medicine (TCM) formula used primarily for renal protection, especially in the context of diabetic nephropathy. It is available as both a grain and a decoction formulation. The formula has been studied for its additive effect when combined with angiotensin receptor blockers (ARBs), showing improvement in albuminuria and Traditional Chinese Medicine Symptom scores in patients with type 2 diabetes mellitus who are normotensive[1][2]. Preclinical studies indicate that it can reduce serum creatinine and proteinuria, inhibit renal fibrosis, and modulate the renin-angiotensin system by downregulating proteins such as α-SMA, TGF-β, renin, and AT1[3]. Its mechanism appears to involve inhibition of renal fibrosis pathways and modulation of the RAS system.
- Brand names
- Qidan Dihuang grainQidan Dihuang decoction
- Other names
- QDDHGQidan Dihuang grain
02
Targets
TGFB (GARP–latent transforming growth factor beta 1 complex)REN (Renin)AGTR1 (Angiotensin II Type-1 receptor)
Beyond the preview
Go deeper on Qidan Dihuang.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qidan Dihuang.